Artificial cells biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy by Thomas Ming Swi Chang.
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
Item type | Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
Himalayan Pharmacy Institute Library | 615.39 CHA/A (Browse shelf(Opens below)) | Not for loan | 02213 |
Browsing Himalayan Pharmacy Institute Library shelves Close shelf browser (Hides shelf browser)
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
615.329 LOR/A Antibiotics in laboratory medicine | 615.329 WEI/A Antibiotics, isolation, separation, and purification | 615.32903 BYC/D Dictionary of antibiotics and related substances | 615.39 CHA/A Artificial cells | 615.4 Practical Physical Pharmacy | 615.4 AHI/H Fundamentals of Hospital and Clinical Pharmacy | 615.4 ALA/P A practical book of pharmaceutics-I |
Includes bibliographical references (p. 377-440) and index.
50th anniversary of artificial cells -- Basic principles -- Oxygen carriers based on nanobiotechnology -- A nanobiotechnologic therapeutic that transports oxygen and remove oxygen radicals: for stroke, hemorrhagic shock and related conditions -- Nanotechnology-based artificial red blood cells (RBC's) -- Use of enzyme artificial cells for genetic enzyme defects that increase systemic substrates to toxic levels -- Enzyme artificial cells in substrate-dependent tumors and activation of prodrug -- Artificial cells for cell encapsulation -- Artificial cells containing hepatocytes and/or stem cells in regenerative medicine -- Hemoperfusion in poisoning, kidney failure, liver failure, and immunology -- Perspectives on the future of artificial cells as suggested by past research.
There are no comments on this title.